Herpes zoster vaccine live: a 10 year review of post-marketing safety experience

ED Willis, M Woodward, E Brown, Z Popmihajlov… - Vaccine, 2017 - Elsevier
Background Zoster vaccine is a single dose live, attenuated vaccine (ZVL) indicated for
individuals≥ 50 years-old for the prevention of herpes zoster (HZ). Safety data from clinical …

Management of systemic sclerosis-associated interstitial lung disease

D Roofeh, S Jaafar, D Vummidi… - Current opinion in …, 2019 - journals.lww.com
The specter of rapidly progressive lung disease requires clinicians to risk stratify patients
according to known predictors for progression and rigorously monitor for symptoms and …

Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort

I Hmamouchi, K Winthrop, O Launay, M Dougados - Vaccine, 2015 - Elsevier
Abstract Background Rheumatoid Arthritis (RA) patients are at increased risk of suffering
from respiratory infections than the general public. Vaccinations against Streptococcus …

Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency

P Loubet, S Kernéis, M Groh, P Loulergue, P Blanche… - Vaccine, 2015 - Elsevier
Background Immunocompromised patients are at increased risk for severe influenza and
invasive pneumococcal diseases. Population-specific vaccine recommendations are thus …

Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying …

C Bombardier, GS Hazlewood, P Akhavan… - The Journal of …, 2012 - jrheum.org
Objective. The Canadian Rheumatology Association (CRA) has developed
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …

[HTML][HTML] The autoimmune ecology

JM Anaya, C Ramirez-Santana, MA Alzate… - Frontiers in …, 2016 - frontiersin.org
Autoimmune diseases (ADs) represent a heterogeneous group of disorders that affect
specific target organs or multiple organ systems. These conditions share common …

[HTML][HTML] A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review

M Soy, G Keser, P Atagunduz, MY Mutlu, A Gunduz… - Clinical …, 2021 - Springer
The COVID-19 pandemic has occupied the world agenda since December 2019. With no
effective treatment yet, vaccination seems to be the most effective method of prevention …

[HTML][HTML] Comorbidities in spondyloarthritis

A Moltó, E Nikiphorou - Frontiers in medicine, 2018 - frontiersin.org
Comorbidities in spondyloarthritis (SpA) add to the burden of disease by contributing to
disease activity, functional and work disability, and mortality. Thus, awareness of …

A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management

N Bansal, C Pasricha, P Kumari, S Jangra, R Kaur… - Autoimmunity …, 2023 - Elsevier
Rheumatoid Arthritis (RA) is a progressive autoimmune disease. It is among the most
widespread chronic illnesses in children, with an annual incidence of 1.6 to 23 new …

[HTML][HTML] Preliminary data on post market safety profiles of COVID 19 vaccines in rheumatic diseases: assessments on various vaccines in use, different rheumatic …

C Rotondo, FP Cantatore, M Fornaro, R Colia, G Busto… - Vaccines, 2021 - mdpi.com
An increased risk of developing severe infections has been evidenced in rheumatic disease
(RD) patients, and anti-COVID-19 vaccination is strictly recommended for RD patients …